Relationship Between Measures of Infliximab Exposure and Clinical Outcome of Infliximab Intensification At Therapeutic Failure in Crohn's Disease

被引：0
|
作者：
Steenholdt, Casper
Edlund, Helena
Ainsworth, Mark A.
Brynskov, Jorn
Thomsen, Ole
Huisinga, Wilhelm
Kloft, Charlotte
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1285
引用
收藏
页码：S848 / S848
页数：1
相关论文
共 50 条
  • [21] Need for infliximab dose intensification in Crohn's disease and ulcerative colitis
    Taxonera, Carlos
    Olivares, David
    Mendoza, Juan L.
    Diaz-Rubio, Manuel
    Rey, Enrique
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (27) : 9170 - 9177
  • [22] Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease
    Dreesen, Erwin
    Berends, Sophie
    Laharie, David
    D'Haens, Geert
    Vermeire, Severine
    Gils, Ann
    Mathot, Ron
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (01) : 106 - 118
  • [23] Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn's Disease
    Gagniere, C.
    Beaugerie, L.
    Pariente, B.
    Seksik, P.
    Amiot, A.
    Abitbol, V.
    Allez, M.
    Cosnes, J.
    Sokol, H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (04): : 349 - 355
  • [24] Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab
    Husman, Julia
    Cerna, Karin
    Matthes, Katja
    Gilger, Maximilian
    Arsova, Maia
    Schmidt, Alexandra
    Winzer, Nadia
    Brosch, Anna-Magdalena
    Brinkmann, Franz
    Hampe, Jochen
    Zeissig, Sebastian
    Lukas, Milan
    Schmelz, Renate
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
  • [25] Need for infliximab dose intensification in Crohn's disease and ulcerative colitis
    Carlos Taxonera
    David Olivares
    Juan L Mendoza
    Manuel Díaz-Rubio
    Enrique Rey
    World Journal of Gastroenterology, 2014, 20 (27) : 9170 - 9177
  • [26] Intensification of Infliximab (IFX) Therapy in Crohn's Disease: Efficacy and Safety
    Chaparro, Maria
    GASTROENTEROLOGY, 2009, 136 (05) : A660 - A660
  • [27] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363
  • [28] Infliximab for Crohn's disease
    Verspaget, HW
    van der Zon, AM
    Gao, Q
    van Hogezand, RA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 2041 - 2042
  • [29] Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease
    Ben-Bassat, Ofer
    Romanova, Anna
    Iacono, Anna
    Irwin, Sue P.
    Greenberg, Gordon R.
    GASTROENTEROLOGY, 2013, 144 (05) : S775 - S775
  • [30] Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure
    Edlund, Helena
    Grisic, Ana-Marija
    Steenholdt, Casper
    Ainsworth, Mark A.
    Brynskov, Torn
    Huisinga, Wilhelm
    Kloft, Charlotte
    THERAPEUTIC DRUG MONITORING, 2019, 41 (02) : 235 - 242
12345